David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Karine BAUMSTARCK, Medical Doctor, MD, PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Délégation à la Recherche Clinique et à l'innovation

Calaméo - Research cartography at Nice University Hospital

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Sarah Lemoine - AHU - CHU de Nantes

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Abstract Book - PDF - San Antonio Breast Cancer Symposium

Eric GUEDJ, Head of Nuclear Medicine Department, MD, PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service de médecine nucléaire (Hôpital Nord)

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19, Genome Medicine

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

APHM - Assistance Publique - Hôpitaux de Marseille, Hôpital public à Marseille

session

Laurent ZIELESKIEWICZ, PhD, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service d'anesthésie réanimation

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19